Product overview
| Name | PPDA |
| Description | Potent GluN2C / GluN2D subunit selective NMDA receptor antagonist |
| Purity | >98% |
Write Your Own Review
Biological Data
| Biological description | Potent GluN2C and GluN2D subunit selective NMDA receptor antagonist (Ki values are 96, 125 nM and 0.31, 0.55 µM for GluN2C, GluN2D, GluN2B and GluN2A subunits respectively). Shows protective effects against Alzheimer's disease. |
Solubility & Handling
| Storage instructions | +4°C |
| Solubility overview | Soluble in NaOH(aq) (50mM, 2eq. NaOH) or DMSO (100mM) |
| Important | This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
| Purity | >98% |
| Chemical name | (2S*,3R*)-1-(Phenanthren-2-carbonyl )piperazine-2,3-dicarboxylic acid |
| Molecular Weight | 378.38 |
| Chemical structure | ![PPDA [684283-16-7] Chemical Structure](https://hellobio.com/media/catalog/product//h/b/hb0531.png "PPDA [684283-16-7]") |
| Molecular Formula | C21H18N2O5 |
| CAS Number | 684283-16-7 |
| PubChem identifier | 90488770 |
| SMILES | O=C(C2=CC=C3C(C=CC4=C3C=CC=C4)=C2)N1[C@@H]([C@](O)=O)[C@@H]([C@](O)=O)NCC1.O=C(C6=CC=C7C(C=CC8=C7C=CC=C8)=C6)N5[C@H](C(O)=O)[C@H](C(O)=O)NCC5 |
| Source | Synthetic |
| InChi | InChI=1S/C21H18N2O5/c24-19(23-10-9-22-17(20(25)26)18(23)21(27)28)14-7-8-16-13(11-14)6-5-12-3-1-2-4-15(12)16/h1-8,11,17-18,22H,9-10H2,(H,25,26)(H,27,28)/t17-,18+/m1/s1 |
| InChiKey | FAQARVDXAFZICA-QVUSPSOHSA-N |
| Appearance | White solid |
References for PPDA
References are publications that support the biological activity of the product
-
The preventive effect of NR2B and NR2D-containing NMDAR antagonists on Aβ-induced LTP disruption in the dentate gyrus of rats.
Zhang J et al (2013) Metab Brain Dis 28(4) : 697-704. -
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket.
Kinarsky L et al (2005) J Pharmacol Exp Ther 313(3) : 1066-74. -
Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.
Feng B et al (2004) Br J Pharmacol 141(3) : 508-16.
Technical guides
Understanding purity and quality - a guide for life scientistsRelated Products
